After more than five months of strict oversight, MEDOcare Health Systems, Inc. has been released from conservatorship by the Insurance Commission. The regulatory hold, initially imposed in June, has officially been lifted as of December 16th, signaling a significant turning point for the health maintenance organization.
The original cease-and-desist order stemmed from ongoing issues with the HMO’s adherence to product approval requirements set forth by the Insurance Commission. This led to a halt in new business operations and the placement of the company under conservatorship, a measure designed to protect policyholders and ensure financial stability.
However, recent financial reports indicate a positive shift within the organization. Data reveals that MEDOcare posted a net income of P12.6 million during the first quarter of 2025, demonstrating a return to profitability.
As of March, the company’s financial standing showed assets totaling P374.8 million against liabilities of P193.5 million. This improved financial position played a crucial role in the Insurance Commission’s decision to lift the conservatorship and allow MEDOcare to resume normal operations.
The lifting of the order represents a successful navigation of regulatory challenges for MEDOcare, allowing the HMO to move forward and continue serving its members without the constraints of conservatorship.
